How severe is CVE-2022-37016?

CVE-2022-37016 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-37016 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (48th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-37016?

CVE-2022-37016 affects Broadcom Symantec Endpoint Protection. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-37016?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2022-37016 published?

CVE-2022-37016 was published on 2022-12-01 and last updated on 2026-06-17.

CVE-2022-37016

CVE-2022-37016 is a critical-severity vulnerability in Broadcom Symantec Endpoint Protection with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
EPSS exploit prediction: 1% (48th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Broadcom Symantec Endpoint Protection
Published: 2022-12-01
Last modified: 2026-06-17

Description

Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.

Frequently asked questions

What is CVE-2022-37016?: Symantec Endpoint Protection (Windows) agent may be susceptible to a Privilege Escalation vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated access to resources that are normally protected from an application or user.
How severe is CVE-2022-37016?: CVE-2022-37016 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-37016 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (48th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-37016?: CVE-2022-37016 affects Broadcom Symantec Endpoint Protection. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-37016?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2022-37016 published?: CVE-2022-37016 was published on 2022-12-01 and last updated on 2026-06-17.

References

https://support.broadcom.com/web/ecx/support-content-notification/-/external/content/SecurityAdvisories/0/21014

Affected products (1)

cpe:2.3:a:broadcom:symantec_endpoint_protection:*:*:*:*:*:windows:*:*

More vulnerabilities in Broadcom Symantec Endpoint Protection

CVE-2022-25631 — High (CVSS 7.8): Symantec Endpoint Protection, prior to 14.3 RU6 (14.3.9210.6000), may be susceptible to a Elevation of Privilege…
CVE-2022-37017 — High (CVSS 7.5): Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security…

All CVEs affecting Broadcom Symantec Endpoint Protection →